SHULAN CITY JINMA CHEMICALS CO., LTD.

JINMA dedicates to chiral pharmaceutical intermediates’ research, developing and producing according to ISO9001/14001, by own macromolecular crosslinking chiral splitting catalyst which developed together with China Institute of Science: patent No. : CN1579626A. No infringement to Rodia’s SalenCo(Ⅱ) patent We are in the first group to have the optical purity above 99.9% products worldwide (except bio-way). Our main products: S/R-Epichlorohydrin, L-Carnitine series ( L-carnitine base, L-carnitine L-tartrate), S/R-1,2-Epoxypropane, , S/R-3-Chloro-1,2-propanediol, etc.